BeOne Medicines, Ltd. American Depositary Receipt (49BA)
FSX
Real-time Data
06:00 AM
Day's Range
306.0052 wk Range
222.00Overview - 49BA - BeOne Medicines, Ltd. American Depositary Receipt
Key Statistics
Valuation
Enterprise Value
28.28B
P/E (Trailing)
‪66.66‬
P/E (Forward)
‪-24.86‬
PEG Ratio
‪0.51‬
Price / Sales (TTM)
‪5.86‬
Price / Book
‪8.10‬
EV / EBITDA
‪30.89‬
Profitability
Gross Margin
‪89.76%‬
Profit Margin
‪10.69%‬
Operating Margin
‪19.06%‬
Return on Assets
‪7.45%‬
Return on Equity
‪14.66%‬
Ownership
Shares Outstanding
1.46B
Float
80.95M
Held by Insiders
‪17.27%‬
Held by Institutions
‪33.12%‬
Price stats
Beta
‪0.50‬
50-Day Avg
‪267.88‬
200-Day Avg
‪268.19‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 49BA - BeOne Medicines, Ltd. American Depositary Receipt
Peers - 49BA - BeOne Medicines, Ltd. American Depositary Receipt
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change66.67P/E (Trailing)‪10.69%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+82.32%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- 22UAFSXBioNTech SE25.39BMarket Cap+6.80%52-week change157.87P/E (Trailing)‪-63.63%‬Profit Margin
Profile Summary - 49BA - BeOne Medicines, Ltd. American Depositary Receipt
About
BeOne Medicines, Ltd. American Depositary Receipt represents ownership in BeOne Medicines Ltd., a Switzerland-domiciled global oncology company headquartered in Cambridge, Massachusetts with corporate operations there and primary offices in Basel, Switzerland. The company discovers, develops, and commercializes…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
